Teva Pharmaceutical Industries (TEVA) Net Income - Minority (2016 - 2025)
Historic Net Income - Minority for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to -$4.0 million.
- Teva Pharmaceutical Industries' Net Income - Minority rose 4285.71% to -$4.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.0 million, marking a year-over-year increase of 4285.71%. This contributed to the annual value of -$4.0 million for FY2025, which is 4285.71% up from last year.
- As of Q4 2025, Teva Pharmaceutical Industries' Net Income - Minority stood at -$4.0 million, which was up 4285.71% from -$4.0 million recorded in Q3 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Net Income - Minority peaked at -$4.0 million during Q3 2025, and registered a low of -$987.0 million during Q2 2021.
- Over the past 5 years, Teva Pharmaceutical Industries' median Net Income - Minority value was -$638.0 million (recorded in 2023), while the average stood at -$529.5 million.
- In the last 5 years, Teva Pharmaceutical Industries' Net Income - Minority crashed by 154.32% in 2021 and then surged by 9887.1% in 2024.
- Teva Pharmaceutical Industries' Net Income - Minority (Quarter) stood at -$966.0 million in 2021, then increased by 17.81% to -$794.0 million in 2022, then increased by 21.91% to -$620.0 million in 2023, then surged by 98.87% to -$7.0 million in 2024, then soared by 42.86% to -$4.0 million in 2025.
- Its Net Income - Minority stands at -$4.0 million for Q4 2025, versus -$4.0 million for Q3 2025 and -$7.0 million for Q2 2025.